<?xml version="1.0" encoding="UTF-8"?><!-- Converted from Majour with majour2a++ V1.11 --><!--Automatically converted from version 2.3 to 2.4--><!DOCTYPE Publisher PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
   <PublisherInfo>
      <PublisherName>Springer-Verlag</PublisherName>
      <PublisherLocation>Berlin/Heidelberg</PublisherLocation>
   </PublisherInfo>
   <Journal>
      <JournalInfo JournalProductType="Legacy" NumberingStyle="Unnumbered">
         <JournalID>401</JournalID>
         <JournalPrintISSN>0001-6322</JournalPrintISSN>
         <JournalElectronicISSN>1432-0533</JournalElectronicISSN>
         <JournalSPIN/>
         <JournalTitle>Acta Neuropathologica</JournalTitle>
         <JournalSubTitle/>
         <JournalAbbreviatedTitle>Acta Neuropathol</JournalAbbreviatedTitle>
<JournalSubjectGroup>
<JournalSubject Type="Primary">Legacy</JournalSubject>
</JournalSubjectGroup>
      </JournalInfo>
      <Volume>
         <VolumeInfo VolumeType="Regular">
<VolumeIDStart>101</VolumeIDStart>
<VolumeIDEnd>101</VolumeIDEnd>
<VolumeIssueCount/>
</VolumeInfo>
         <Issue IssueType="Regular">
            <IssueInfo TocLevels="0">
               <IssueIDStart>1</IssueIDStart>
               <IssueIDEnd>1</IssueIDEnd>
               <IssueHistory>
                  <OnlineDate>
                     <Year>2000</Year>
                     <Month>9</Month>
                     <Day>5</Day>
                  </OnlineDate>
                  <PrintDate>
                     <Year>2001</Year>
                     <Month>1</Month>
                     <Day/>
                  </PrintDate>
                  <CoverDate>
                     <Year>2001</Year>
                     <Month>1</Month>
                  </CoverDate>
               </IssueHistory>
               <IssueCopyright>
                  <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                  <CopyrightYear>2000</CopyrightYear>
               </IssueCopyright>
            </IssueInfo>
            <Article ID="Art1">
               <ArticleInfo ArticleType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="Unnumbered" TocLevels="0">
                  <ArticleID>00256</ArticleID>
                  <ArticleDOI>10.1007/s004010000256</ArticleDOI>
                  <ArticleTitle Language="En">Neuronal and glial advanced glycation end product [<Emphasis Type="Italic">N</Emphasis>
                     <Superscript>ε</Superscript>-(carboxymethyl)lysine] in Alzheimer's disease brains</ArticleTitle>
                  <ArticleCategory>Regular Paper</ArticleCategory>
                  <ArticleFirstPage>27</ArticleFirstPage>
                  <ArticleLastPage>35</ArticleLastPage>
                  <ArticleHistory>
                     <Received>
                        <Year>2000</Year>
                        <Month>01</Month>
                        <Day>14</Day>
                     </Received>
                     <Revised>
                        <Year>2000</Year>
                        <Month>03</Month>
                        <Day>08</Day>
                     </Revised>
                     <Accepted>
                        <Year>2000</Year>
                        <Month>05</Month>
                        <Day>02</Day>
                     </Accepted>
                  </ArticleHistory>
                  <ArticleCopyright>
                     <CopyrightHolderName>Springer-Verlag</CopyrightHolderName>
                     <CopyrightYear>2000</CopyrightYear>
                  </ArticleCopyright>
<ArticleGrants>
<MetadataGrant Grant="OpenAccess"/>
<AbstractGrant Grant="OpenAccess"/>
<BodyPDFGrant Grant="Restricted"/>
<BodyHTMLGrant Grant="Restricted"/>
<BibliographyGrant Grant="Restricted"/>
<ESMGrant Grant="Restricted"/>
</ArticleGrants>
               </ArticleInfo>
               <ArticleHeader>
                  <AuthorGroup>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Akinori</GivenName>
                           <FamilyName>Takeda</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Masakazu</GivenName>
                           <FamilyName>Wakai</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Hisayoshi</GivenName>
                           <FamilyName>Niwa</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Rika</GivenName>
                           <FamilyName>Dei</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Masahiko</GivenName>
                           <FamilyName>Yamamoto</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Mei</GivenName>
                           <FamilyName>Li</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Yoji</GivenName>
                           <FamilyName>Goto</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Takeshi</GivenName>
                           <FamilyName>Yasuda</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A3">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Yuji</GivenName>
                           <FamilyName>Nakagomi</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A4">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Masaki</GivenName>
                           <FamilyName>Watanabe</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A5">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Toshiaki</GivenName>
                           <FamilyName>Inagaki</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Yoshinari</GivenName>
                           <FamilyName>Yasuda</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A6">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Toshio</GivenName>
                           <FamilyName>Miyata</FamilyName>
                        </AuthorName>
                     </Author>
                     <Author AffiliationIDS="A1">
                        <AuthorName DisplayOrder="Western">
                           <GivenName>Gen</GivenName>
                           <FamilyName>Sobue</FamilyName>
                        </AuthorName>
                        <Contact>
                           <Phone>+81-52-7442385</Phone>
                           <Fax>+81-52-7442384</Fax>
                           <Email>sobueg@tsuru.med.nagoya-u.ac.jp</Email>
                        </Contact>
                     </Author>
                     <Affiliation ID="A1">
                        <OrgName>Department of Neurology, Nagoya University School of Medicine, Tsurumai 65, Showa, Nagoya 466-8550, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A2">
                        <OrgName>Department of Neurology, Oyamada Memorial Spa Hospital, Yokkaichi, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A3">
                        <OrgName>Laboratory of Electron Microscopy, Aichi Medical University, Aichi, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A4">
                        <OrgName>Department of Neurology, Nagoya First Red Cross Hospital, Nagoya, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A5">
                        <OrgName>Department of Internal Medicine, Nagoya City Kouseiin Geriatric Hospital, Nagoya, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                     <Affiliation ID="A6">
                        <OrgName>Institute of Medical Science and Department of Medicine, Tokai University, Kanagawa, Japan</OrgName>
                        <OrgAddress>
                           <Street/>
                           <Postbox/>
                           <Postcode/>
                           <City/>
                           <State/>
                        </OrgAddress>
                     </Affiliation>
                  </AuthorGroup>
                  <Abstract ID="Abs1" Language="En">
                     <Heading>Abstract.</Heading>
                     <Para> The cellular distribution of an advanced glycation end product [<Emphasis Type="Italic">N</Emphasis>
                        <Superscript>ε</Superscript>-(carboxymethyl)lysine (CML)] in aged and Alzheimer's disease (AD) brains was assessed immunohistochemically. CML was localized in the cytoplasm of neurons, astrocytes, and microglia in both aged and AD brains. Glial deposition was far more marked in AD brains than in aged brains, and neuronal deposition was also increased. On electron microscopic immunohistochemistry, neuronal CML formed granular or linear deposits associated with lipofuscin, and glial deposits formed lines around the vacuoles. Neuronal and glial deposits were prominent throughout the cerebral cortex and hippocampus, but were sparse in the putamen, globus pallidus, substantia nigra, and cerebellum, with glial deposits being far more prominent in AD brains. The distribution of neuronal and glial deposits did not correspond with the distribution of AD pathology. The extent of CML deposits was inversely correlated with neurofibrillary tangle formation, particularly in the hippocampus. Most hippocampal pyramidal neurons with neurofibrillary tangles did not have CML, and most of the neurons with heavy CML deposits did not have neurofibrillary tangles. In the hippocampus, neuronal CML was prominent in the region where neuronal loss was mild. These observations suggest that CML deposition does not directly cause neurofibrillary tangle formation or neuronal loss in AD.</Para>
                  </Abstract>
                  <KeywordGroup Language="En">
                     <Keyword>Advanced glycation end products Nε-(Carboxymethyl)lysine Astrocyte Microglia Oxidative stress</Keyword>
                  </KeywordGroup>
                  <ArticleNote Type="Misc">
                     <SimplePara>Electronic Publication</SimplePara>
                  </ArticleNote>
               </ArticleHeader>
               <BodyRef FileRef="BodyRef/PDF/401_2001_Article_256.pdf" TargetType="PDF"/>
            </Article>
         </Issue>
      </Volume>
   </Journal>
</Publisher>